Search

Author/Creator Wei, Shaoceng

1. Efficacy and safety of ruxolitinib cream for the treatment of vitiligo by patient demographics and baseline clinical characteristics: Week 52 pooled subgroup analysis from two randomized phase 3 studies. (18th January 2023)

Authors:
Seneschal, Julien; Wolkerstorfer, Albert; Desai, Seemal R; Grimes, Pearl; Ezzedine, Khaled; Kornacki, Deanna; Wei, Shaoceng; Butler, Kathleen; Rosmarin, David
Journal:
British journal of dermatology
Issue:
Volume 188(2023)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis. (21st September 2022)

Authors:
Blauvelt, Andrew; Kircik, Leon; Papp, Kim A.; Simpson, Eric L.; Silverberg, Jonathan I.; Kim, Brian S.; Kwatra, Shawn G.; Kuligowski, Michael E.; Venturanza, May E.; Wei, Shaoceng; Szepietowski, Jacek C.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 37:Number 1(2023)
Page Start:
137
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗